2011
DOI: 10.1016/j.jpedsurg.2011.02.027
|View full text |Cite
|
Sign up to set email alerts
|

Sclerotherapy for lymphatic malformations in children: a scoping review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
72
1
3

Year Published

2014
2014
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 75 publications
(77 citation statements)
references
References 45 publications
0
72
1
3
Order By: Relevance
“…84 Since the first studies carried out by Ogita et al, 85 OK-432 (Picibanil; Chugai Pharmaceutical Co. Ltd, Tokyo, Japan) has proven to be the most suitable drug. The numerous works published, 85,86 also analysed OK-432 in comparison with other sclerosing agents, confirm that OK-432 is the less invasive drug, with a higher average response, and characterized by an effectiveness ranging from 85% to 98%. Experience with sclerosing therapy of the microcystic lymphangioma using OK-432 has led to disappointing results, with an efficacy of 33%.…”
Section: Osteoid Osteomamentioning
confidence: 82%
“…84 Since the first studies carried out by Ogita et al, 85 OK-432 (Picibanil; Chugai Pharmaceutical Co. Ltd, Tokyo, Japan) has proven to be the most suitable drug. The numerous works published, 85,86 also analysed OK-432 in comparison with other sclerosing agents, confirm that OK-432 is the less invasive drug, with a higher average response, and characterized by an effectiveness ranging from 85% to 98%. Experience with sclerosing therapy of the microcystic lymphangioma using OK-432 has led to disappointing results, with an efficacy of 33%.…”
Section: Osteoid Osteomamentioning
confidence: 82%
“…One of the most safe and effective ways of cystic LMs treatment in children is the OK-432 sclerotherapy [5,16]. The OK-432 (Chugai Pharmaceuticals, Tokyo, Japan) is a lyophilized powder of Streptococcus pyogenes (group A, type 3, Su strain) incubated with benzylpenicillin.…”
Section: Discussionmentioning
confidence: 99%
“…These lesions are present at birth and have a progressive clinical course. The incidence of LMs is evidenced in about 1 to 6000 to 1 to 16,000 live births, with a frequency of hospitalization -3 cases per 100,000 [4,5]. LMs near the principal lymphatic chains in the neck region are formed when a primordial lymph sac loses or fails to re-establish communication with the central veins (jugular and subclavian) from which it arises [1].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…La chirurgie est donc souvent privilégiée, nécessitant souvent d'établir un compromis entre des résultats esthétiques et fonctionnels acceptables et des délabrements importants. La radiofréquence consistant à créer des lésions thermiques en profondeur dans le but de diminuer la taille des ML est égale-ment une option thérapeutique envisageable [18,28,29]. Enfin, l'interféron alpha et 2b [29,30] et le cyclophosphamide [16] ont été employés dans certaines malformations lymphatiques étendues, symptomatiques et inopérables, traitements qui semblent stabiliser les lésions mais dont la tolérance est mauvaise avec un recul actuellement insuffisant pour en connaître les effets secondaires.…”
Section: Fig 2 Patient N° 1 Axial Slices In T1 Without Gadolinium unclassified